You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Drug Price Trends for NDC 00093-7536


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00093-7536

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 00093-7536

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. This code identifies the labeler, product, and trade package size of a drug product[1][5].

Identifying the Drug

The NDC 00093-7536 is a specific identifier that corresponds to a particular drug product. To identify the drug, one would need to refer to the FDA's National Drug Code Directory or other pharmaceutical databases. However, for the purpose of this analysis, let's assume this NDC corresponds to a commonly used medication.

Market Trends in the Pharmaceutical Industry

Overall Industry Outlook

The pharmaceutical industry is expected to experience a stable credit outlook in 2024, with a mix of upgrades and downgrades driven by factors such as deleveraging and debt-financed mergers and acquisitions. The generic drug industry, in particular, is anticipated to face mid-single-digit percent annual price erosion but is expected to return to modest revenue growth[3].

Price Dynamics

Prices in the pharmaceutical industry, especially in the U.S., are significantly higher compared to other regions. In 2022, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as the rest of the world (excluding the U.S.). This disparity is due to both higher prices for the same drugs and a drug mix that skews towards more expensive compounds in the U.S.[4].

Segment-Specific Trends

Generic Drugs

The generic drug market is expected to see price erosion, but with a return to modest revenue growth. This segment is highly competitive and subject to price pressures, which could impact the pricing of generic versions of the drug identified by NDC 00093-7536[3].

Biologic and Biosimilar Drugs

Biologic products have seen significant revenue growth, with U.S. sales revenues growing by 61% between 2017 and 2022. Biosimilars, which are biologic products with similar active ingredients, are also expected to see substantial revenue growth, although intense competition may limit profitability[4].

Price Projections for NDC 00093-7536

Current Pricing

To determine the current price of the drug identified by NDC 00093-7536, one would typically refer to pricing lists such as those provided by state health departments or pharmaceutical pricing databases. For example, the Missouri Specialty MAC list provides detailed pricing information for various drugs, including their NDC numbers[2].

Future Pricing Trends

Given the overall trends in the pharmaceutical industry:

  • Price Erosion: If the drug is a generic or has generic equivalents, it may face price erosion, leading to a decrease in its price over time.
  • Revenue Growth: If the drug is a biologic or biosimilar, it might experience revenue growth, although this could be tempered by intense competition.
  • Regulatory Factors: FDA inspections and potential price-fixing litigation could impact pricing strategies and stability in the market[3].

Regional Pricing Disparities

The significant price disparities between the U.S. and other regions suggest that the drug's price could be influenced by regional market dynamics. In the U.S., prices are generally higher, which could affect the pricing strategy for this drug[4].

Key Factors Influencing Price Projections

Regulatory Compliance

The drug's inclusion in the NDC Directory and compliance with FDA regulations are crucial. Any changes in regulatory requirements or non-compliance could affect the drug's market presence and pricing[1][5].

Market Competition

The level of competition in the market segment where the drug operates will significantly influence its pricing. For generic drugs, competition is typically high, leading to lower prices. For biologics and biosimilars, competition is also increasing, which could impact pricing strategies[3].

Economic and Healthcare Policy Changes

Changes in healthcare policies, reimbursement rates, and economic conditions can also impact the pricing of pharmaceuticals. For instance, policies aimed at reducing drug prices or increasing transparency could affect the market dynamics[4].

Conclusion

The market analysis and price projections for the drug identified by NDC 00093-7536 depend on several factors, including the drug's category (generic, biologic, etc.), regulatory compliance, market competition, and broader economic and healthcare policy changes. Here are some key takeaways:

  • Regulatory Compliance: Ensuring the drug is listed in the NDC Directory and complies with FDA regulations is essential.
  • Market Trends: The drug's price will be influenced by overall industry trends, such as price erosion for generics and revenue growth for biologics and biosimilars.
  • Regional Pricing: The significant price disparities between the U.S. and other regions must be considered.
  • Competition: Market competition will play a crucial role in determining the drug's price.

Key Takeaways

  • NDC Importance: The NDC is a critical identifier for drug products, helping in market analysis and regulatory compliance.
  • Industry Trends: The pharmaceutical industry is expected to see stable credit outlooks, with specific trends in generic and biologic segments.
  • Price Dynamics: Prices in the U.S. are significantly higher than in other regions, influenced by both higher prices and a drug mix skewed towards more expensive compounds.
  • Regulatory and Market Factors: Compliance with FDA regulations and market competition are key factors influencing price projections.

FAQs

What is the National Drug Code (NDC)?

The National Drug Code (NDC) is a unique, three-segment number that identifies drug products, including the labeler, product, and trade package size.

Why is the NDC important for market analysis?

The NDC is crucial for identifying specific drug products and tracking their market presence, pricing, and regulatory compliance.

What are the current trends in the pharmaceutical industry?

The industry is expected to see a stable credit outlook, with mid-single-digit percent annual price erosion for generics and substantial revenue growth for biologics and biosimilars.

How do regional pricing disparities affect drug prices?

Regional pricing disparities, particularly the higher prices in the U.S. compared to other regions, significantly influence the pricing strategy for drugs.

What factors influence price projections for a specific drug?

Price projections are influenced by regulatory compliance, market competition, economic and healthcare policy changes, and overall industry trends.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price - Missouri Department of Social Services
  3. Pharmaceutical Industry 2024 Credit Outlook Is Stable As Revenue Growth Mitigates Pressures - S&P Global
  4. International Market Size and Prices - ASPE
  5. National Drug Code Database Background Information - FDA

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.